Free Trial

DocGo Inc. (NASDAQ:DCGO) Given Average Recommendation of "Moderate Buy" by Analysts

DocGo logo with Medical background

Key Points

  • DocGo Inc. (NASDAQ:DCGO) has received an average recommendation of "Moderate Buy" from six analysts, with a balanced split of three buy ratings and three hold ratings.
  • The company's 1-year price objective averages at $3.59, although several analysts have recently adjusted their target prices downwards.
  • DocGo reported a revenue of $80.42 million for the last quarter, exceeding estimates, but reported a loss of ($0.11) earnings per share, falling short of expected results.
  • Need better tools to track DocGo? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

DocGo Inc. (NASDAQ:DCGO - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six analysts that are presently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $3.59.

A number of research firms recently weighed in on DCGO. Needham & Company LLC decreased their target price on DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a report on Friday, May 9th. BTIG Research lowered DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Finally, Canaccord Genuity Group boosted their target price on DocGo from $1.45 to $1.60 and gave the stock a "hold" rating in a report on Thursday.

Get Our Latest Report on DocGo

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Summit Securities Group LLC acquired a new position in DocGo in the 1st quarter valued at $34,000. CWM LLC grew its holdings in DocGo by 2,613.3% in the 2nd quarter. CWM LLC now owns 21,978 shares of the company's stock valued at $35,000 after buying an additional 21,168 shares in the last quarter. Cerity Partners LLC acquired a new position in DocGo in the 2nd quarter valued at $37,000. Summit Investment Advisors Inc. grew its holdings in DocGo by 38.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock valued at $45,000 after buying an additional 2,968 shares in the last quarter. Finally, Engineers Gate Manager LP acquired a new position in DocGo in the 2nd quarter valued at $52,000. 56.44% of the stock is owned by institutional investors and hedge funds.

DocGo Trading Down 0.6%

DCGO stock opened at $1.60 on Friday. The firm has a market capitalization of $156.50 million, a PE ratio of -8.42 and a beta of 0.96. DocGo has a 1-year low of $1.23 and a 1-year high of $5.6750. The business's 50 day simple moving average is $1.53 and its 200 day simple moving average is $2.32.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.05). The business had revenue of $80.42 million for the quarter, compared to analyst estimates of $77.58 million. DocGo had a negative return on equity of 3.26% and a negative net margin of 4.20%. DocGo has set its FY 2025 guidance at EPS. As a group, sell-side analysts predict that DocGo will post 0.25 EPS for the current fiscal year.

About DocGo

(Get Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Stories

Analyst Recommendations for DocGo (NASDAQ:DCGO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DocGo Right Now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines